Attendee Quotes from the 2017 Next Generation Dx Summit:
"Everyone I talked to thought the meeting was exceptionally good. All of the talks were good and the breadth of the material was excellent."
Professor Emeritus, Genetics, Yale University School of Medicine
"It's a unique event in that it brings together a wide range of leading clinicians and key representatives from the diagnostics industry."
CEO, Atlas Genetics
"The pharma presence increased significantly from last year. The presentations were exceptional and insightful! There were new and various technologies in the exhibit hall and stakeholders from all facets of the industry."
Head of Biomarkers Services and Biosciences, Randox
"The attendees come to the event with a collaborative mindset and are looking for opportunities to advance the standard of research."
CCO, Vortex Biosciences
"More attendance from pharma in 2017 which is what we want to see!"
Chief Marketing Office, MolecularMD
"The Next Gen Dx Summit brought together exceptional content and some of the most highly specialized experts in the field of diagnostics. A fantastic event for those seeking critical knowledge in the lab and IVD space."
Senior Director, Health Policy and Reimbursement, Hologic, Inc.
"I found the meeting productive and met many old friends as well as a number of new contacts. I went into the meeting without many expectations but found that there was a good deal there that was of value to my job functions."
Scientific Project Leadership, Precision Medicine and Diagnostics, R&D ImmunoInflammation, GSK
"I enjoyed the sessions I went to and thought the topics were spot on."
Professor of Pathology, Director, Laboratory for Clinical Genomics and Advanced Technology (CGAT), Department of Pathology and Laboratory Medicine, Dartmouth Hitchcock Medical Center and The Audrey and Theodor Geisel School of Medicine at Dartmouth
"The meeting had outstanding speaker lineup and lots of good discussions in the Q&A sessions."
Assistant Professor, Radiation Oncology, Stanford Cancer Institute, Institute for Stem Cell Biology & Regenerative Medicine, Stanford University
"I truly enjoyed the opportunity to present to and with professionals truly interested in progressing both point-of-care testing and the pharmacy profession. The conference afforded me to opportunity to meet many colleagues who are striving to improve the care of patients either through clinical services or through creating devices that would better benefit our patients. I felt honored to have pharmacists, laboratorians, and as well as manufacturers come and ask me questions regarding improving workflow, devices, and services. Thank you for the opportunity to bring a different perspective to the conference. I learned so much over those few days and I hope I was able to impart knowledge into others."
Clinical Pharmacist, Rx Clinic Pharmacy
"This was an exciting meeting to participate because it provided opportunities for latest updates and cutting-edge investigations in biomarkers/clinical intervention, regulatory guidelines for translational/clinical work, and synergies and networking with colleagues in the biomedical space."
Director, Center of the Biomarker Research Program, The Methodist Hospital Research Institute
"I thought this was an excellent conference to bring together industry and academia around specific topics, such as circulating biomarkers. There is clearly a disconnect between those in the medical profession who desire clinical utility and those in industry who have a new product that they want to be used quickly. This conference helps to bridge that divide to help ensure that new devices and biomarkers can demonstrate clinical utility for patients and find their way toward regulatory approval and reimbursement."
Associate Professor of Medicine, Duke Cancer Institute
Attendee Quotes from the 2016 Next Generation Dx Summit:
"NGDx16 offered relevant and current talks by thought leaders in the field of infectious disease diagnostics and surveillance, followed by healthy discussions. During the show I was able to connect with several companies and researchers I had heard about, and we ended up exploring collaborations with several of them. All in all I think the Next Generation Dx Summit is a great meeting in the field of new diagnostics, and I definitely plan to attend again next year."
Senior Program Officer, Life Science Partnerships, The Bill and Melinda Gates Foundation
"The size and quality of the Next Generation Dx Summit is growing exponentially with each year, and quickly becoming a key industry event for experts and stakeholders in the diagnostics space. CHI is doing an impressive job of making Washington D.C. in August ‘the place to be.'"
Principal, Bruce Quinn Associates
"It’s motivational and individual with different expertise, areas and backgrounds; whether it be academic vs. diagnostics vs. point of care, we all come together which is complementary, and ultimately we find a cure. I enjoy interacting at the CHI conferences and it will be my honor to continue, it is a great learning experience."
Director, Center of the Biomarker Research Program, Houston Methodist Hospital Research Institute
"I thought the Molecular Diagnostics for Infectious Disease Conference was fantastic again this year, with very exciting new technologies presented. Once again a fantastic conference!"
Associate Professor of Pathology, Medical Director, Clinical Microbiology, Medical College of Wisconsin
"The Molecular Diagnostics for Infectious Disease Conference was great as usual. I’m always grateful for the connections I make. These connections have been a big boost to our research from years past and I know the ones I made this time will be equally helpful."
Assistant Professor, Medicine, Duke University School of Medicine
"We are delighted to debut our new POC System at the Next Generation Dx Summit. Our system breaks the final diagnostics barrier of bringing molecular testing to physicians. It has been the perfect venue to showcase our technology."
Chief Strategy Officer, Mesa Biotech
"We received seven RFPs onsite at the Next Generation Dx Summit, plus we had many other meaningful conversations."
Director, Business Development, Stilla Technologies
Attendee Quotes from the 2015 Next Generation Dx Summit:
“A concentrated event with more KOLs in attendance than any other conference I have been to.”
CEO, Raindance Technologies
“This is my first time to this meeting and it has been a pleasant surprise. The program is packed with high-quality speakers and top-notch content. It is hard to choose just one talk to see at a time.”
CEO, Biovotion AG
“Conference was AWESOME. A forty page guide! 150 speakers! The wide range of excellent topics. It was really, really stellar.”
Senior Director, FaegreBD Consulting
“One of the best CDx conferences I have been to.”
VP, Corporate & Business Development, Foundation Medicine
Attendee Quotes from the 2013 Next Generation Dx Summit:
“The Next Generation Dx Summit brings together key players from all facets of diagnostic development. Its format is very conducive to networking and learning from the leaders in the field. This is a great meeting for anyone who is serious about pursing diagnostic technologies anywhere from research to commercialization.”
Program Director, Fluxion Biosciences
“As we begin to move from a centralized lab to a point-of-care setting we have faced many challenges. It has been a very rewarding meeting with the leaders in policy making along with the leaders in development all in the same place.”
Pathology, Graves Gilbert Clinic
“Congratulations on a well-run and informative Next Generation Diagnostics Conference and it was very nice to see the highly increased attendance this year!”
Assistant Professor of Pathology, Medical Director, Clinical Microbiology, Dynacare Laboratories and Froedtert Hospital, Medical Director, Molecular Diagnostics, Dynacare Laboratories and Froedtert Hospital
“The Next Gen Dx summit represents an exceptionally focused event bringing together leading researchers and stakeholders in the diagnostics field in a setting that is large enough to provide critical mass and diversity of perspectives without being so large as to make networking and meaningful interactions difficult.”
Senior Director, Sales and Marketing, Quanterix
“Next Gen Dx was a great combination of informative programs that drew very focused attendees. Many of the interactions with attendees were with key decision makers actively engaged in the development of molecular diagnostics.”
Clinical and Commercial Development Specialist, IDT
“Great opportunity to learn about developments and emerging technologies that impact industry. Perfect meeting size, conducive to networking, with a senior-level audience in attendance”
CEO, Slone Partners
“NextGenDx 2013 was a successful meeting. Each successive year improves on the previous. We will definitely be back in 2014!”
“I was pleasantly surprised by the numerous high level Dx contacts at the meeting. It would be extremely difficult to establish these relationships in such a short time without having attended the Next Gen Dx Summit.”
Business Development Manager, Quanterix
“I attended the Cancer Molecular Markers to Guide Therapy conference (part of the Next Generation Dx Summit) in August, 2013. I was extremely glad to have been there. Cancer Molecular Markers provided a solid overview not only of the state of the art in biomarker work, but gave detailed accounts of the successful application of these discoveries in human health. The coverage of the subject was comprehensive. The field of cancer molecular markers is exploding in a variety of directions. Not only did I get to hear what is hot in the standard gene target fields, but I was able to interact with workers at the bleeding edge of such markers as cell-free DNA and EpCAM-negative circulating tumor cells. I congratulate you on bringing in speakers that remind us that our work makes a difference!”
Director, Alliances and Partnerships, Department of Genetics, Washington University School of Medicine
“CHI’s Intronet has been a successful tool for setting up meetings with potential partners”
Sector Manager, Diagnostics, Sagentia
“CHI had a great mix of technical, clinical, and entrepreneurial speakers and topics. Congratulations!”
Professor, Pathology and Laboratory Medicine; Director, Clinical Chemistry and Point-of-Care Testing; Faculty, Biomedical Engineering and Comparative Pathology, University of California, Davis
“I really enjoyed the program this year. There were some really good speakers and lots of great intel for my clients.”
Business Development & Strategic Consulting for Diagnostics Companies, Tynan Consulting LLC
“I found that the audience was a very diverse set of people who were genuinely interested in learning about the mobile health vs medical device world. I had a number of in-depth conversations after my talk with cool people who actually understood the nuances and implications of this new landscape. The breakfast breakout sessions were excellent. I would encourage you to do more of those on different topics. Overall, the best selling point is the diversity of the attendees' backgrounds.”
Chief Technology Officer, AgaMatrix, Inc.
“I found this year’s Next Generation Diagnostics Summit to be very informative. It’s very exciting to hear about the work that is being done and to know that NGS is now being widely used. It was also a wonderful opportunity to network with other NGS users and learn from them. I also enjoyed visiting the booths of the vendors that exhibited their products or services.”
Associate Scientific Director, Advanced Sequencing, Quest Diagnostics Nichols Institute
Attendee Quotes from the 2012 Next Generation Dx Summit:
“The size and setting was ideal for forming new collaborations. I learned a lot about the state of the art in new sample-to-answer diagnostic systems, and am more thrilled than ever to work in this rapidly evolving area of medicine. I was particularly impressed by your efforts to include speakers from the FDA, from medical applications, and from instrument development area in the program. Please continue this conference series, which is tremendously helpful in getting people with similar interests to change medicine from an empirical art to an analytical science together.”
Neches Professor of Electrical Engineering, Applied Physics and Physics, California Institute of Technology
“The 2012 meeting was one of the most productive and informative ones we attended and, as a result, have already signed on as a sponsor for next year's meeting.”
Senior Vice President for Corporate Business Development & Scientific Affairs, Rheonix, Inc.
“Just one talk at the Next Gen Dx Summit taught me more than days pouring over guidance, summary reviews and Ad Con minutes. It is like turbo charging your Regulatory expertise”
Scientist, CATO Research
“The Next Generation Dx Summit 2012 provided an unparalleled combination of relevant presentations and discussion topics with a broad range of participants to allow for both meaningful content and the initiation and strengthening of partnerships to truly support the development of the next generation of diagnostics and companion diagnostics.”
Vice President, Clinical Research Services, ResearchDx, LLC
“Unfortunately, I was only able to attend for a day and a half. But, from what I saw, it was a remarkably well organized meeting, with a wide breadth of content. I saw many familiar faces and met many new ones. This meeting seems to be becoming one of the “must attend” events on the clinical lab meeting calendar, and that is saying something with so many choices.”
Vice President, Commercialization Strategies, Consulting & Industry Affairs, Xifin
“Great conference! Most up to date data. Perfect amalgamation between industry, labs, clinicians and regulatory bodies. Highly recommended!”
Clinical Microbiology Fellow, NIH
“I have been attending since 2008 and this year’s meeting had the best exhibit hall, with exhibits that matched the sessions very well.”
Director of Bus Dev and Sales, Sony DADC
“The 2012 Next Gen Dx Summit was a very worthwhile meeting for us, it provided the opportunity to network with a targeted audience of leaders in the field and the speakers and topics were very relevant to today’s molecular diagnostics community. We look forward to attending next year.”
Director of Sales, PrimeraDx
“I thought it was a topical conference with real-world advice for those wanting to successfully commercialize technology, rather than being just technology for its own sake.”
Principal, McKeon, Meunier, Carlin & Curfman, LLC
“I had a great time at the conference; it was interesting to have so many industry people, and to hear from major figures from FDA and similar organizations. I’d love to be involved in years to come.”
Department of Laboratory Medicine, Yale University School of Medicine; Pathology and Laboratory Medicine, VA Connecticut
“I had not attended this meeting since the previous time I spoke (2010), so I was very surprised to see how much larger it has become. It struck me that there were quite a few good sessions (microbiology and infectious diseases) that I attended but I am sure that there were far more. I was particularly happy to see that FDA senior staff present.”
President & CEO, DOCRO, Inc.
“An excellent conference which provided a lot of interesting information.”
Professor of Health Services Research, Division of Health Sciences, Warwick Medical School
“The facilities and meeting rooms were excellent, the staff were also excellent and moved from room to room to make sure each session started on time, and it was very well managed. The large Plenary Keynote Discussion on Regulation of LDTs and RUO products was excellent. The room was very large and almost every seat was taken! Also a special thank you should go to Dr. Alberto Gutierrez from FDA CDRH for being willing to stand up there alone and answer all those difficult questions from the audience.”
Regulatory Affairs Manager, Bio-Rad Laboratories
“The presentations by Alberto Gutierrez on companion Dx and in the plenary keynote discussion, as well as the presentations by ACLA and AdvaMedDx, were extremely valuable. It was interesting to see the posturing (for lack of a more diplomatic term) by industry and FDA on the yet-to-be released LDT guidance. It was an ideal venue to hear the latest about regulatory guidance from both the FDA and industry.”
Senior Vice President, Marketing, Sales & Business Development, TessArae, LLC
“The meeting was great and I have learned a lot. The program was very diversified and covered most of the area of POC. I am sure small and big companies as well as academicians benefited from this energetic meeting. The posters and the exhibition in the same hall is a great way to connect people as well as the breakfast.”
Director and Founder, Centre de Recherche en Infectiologie de l’Université Laval
“The partnering forum was a very impressive overview not just of novel technologies, but also of the relative readiness levels of the technologies presented. I found it very valuable and a forum for finding collaborators.”
Thrust Area Leader, Molecular Assays & Virology, Lawrence Livermore National Lab
“This was very good and much better than other similar events I have attended”
President, Sharp Technology Ventures
“Great agenda, great companies—looking forward to the next one”
“The Dinner Roundtable “Deal Making in Companion diagnostics: CDx Today and Tomorrow” chaired by Jorge Leon (Leomics Associates President) was especially timely, informative and most remarkable in that Jorge was able to elicit candid and open input from the majority of attendees. Both thought provoking and energizing. …would recommend highly.”
Advisor, Bone and Mineral, DiaSorin inc
“Great forum for networking with experts in the field.”
Clinical Microbiology Fellow, NIH
Attendee Quotes from the 2011 Next Generation Dx Summit:
“The meeting was excellent, one of the best I have attended, and the standard of talks matched to the schedule across the board.”
Vice President, Diagnostics, GlaxoSmithKline
“The Next Generation Dx Summit is the Conference to attend if you seek not only to learn about cutting edge diagnostics but to meet the people who develop and implement them”
R&D Consultant, Randox Laboratories
“This conference is great at bringing us up to date on what is going on in the diagnostics field. The conference gave me insights into all aspects of strategizing, development and implementation of diagnostics. The intensive courses are very thorough and helpful. I would recommend this for other academics because it allows us to touch base with what the industries are also focusing on.”
Professor, Institute for Research in Molecular Medicine
“Anyone planning to introduce a new gene-based clinical test should attend and listen to the excellent guidance on how to solve common problems and challenges they will face.”
President, The Shamel Group Inc.
“The meeting was well organized. I enjoy that there are participants from different backgrounds – from industry and researchers to clinical oncologists.”
Professor, Pathology, Covenant Medical Center
“CHI’s Next Generation Dx Summit stood out as a premier venue for great content and valuable networking.”
Principal, Pricing & Market Access Practice, Scientia Advisors
“The Next Generation Diagnostics Summit was a great meeting with many relevant, timely topics and excellent speakers. CHI’s meetings continue to impress with quality programming.”
CSO, Metamark Genetics
“I sincerely admire the great success of this conference and congratulate you on the job excellently done. This conference is really forging the future cancer diagnoses, prognoses, and therapies.”
Associate Professor of Genetics, Genomics, and Gene Therapy; Director of Biotechnology Program, Western University of Health Sciences
“An excellent opportunity to learn from, and speak with, the relevant stakeholders (pharmaceutical and diagnostic companies, regulatory bodies and healthcare payers) who are driving the development and implementation of leading-edge diagnostic approaches within the healthcare industry.”
Senior Director, Business Development, Theranostics Health, Inc.
”Well informed meeting with key opinion leaders from commercial labs to clinical labs and manufacturers of molecular diagnostics”
Manager of Product Marketing, Luminex Diagnostics
”The Next Gen Dx Summit was a superb event. The talks were very informative and we will definitely be sponsoring the conference again next year”
Global Manager, Randox Laboratories
“For people in IVD development, the number and quality of attendees was significantly better than that of an industry tradeshow.”
VP, Clinical Research Services, ResearchDx, LLC
“Great audience, interesting presentations, well attended by important thought leaders in the industry. There were great perspectives on what it takes to bring diagnostics to the market place.”
Director, Sales and Marketing, Primera Dx
“… highly focused meetings such as the Next Gen Dx Summit provide manufacturers the ideal venue for presenting innovative products and ideas to important opinion leaders actively engaged at the forefront of developments in the molecular diagnostics field.”
Director, Marketing and Sales, Biosearch Technologies
“Well, we did have a few problems at the Next Gen Dx Summit. We ran out of business cards; we almost ran out of brochures; customers had to queue to talk to our staff at times. We could do with similar problems at all the exhibitions we do!”
Head of Marketing, Renishaw Diagnostics
“The meeting was very worthwhile. Engaged audience, interesting presentations, well attended by decision makers leaders in the industry. We enjoyed exciting discussions which gave us perspective on where our technology fits in the market.”
VP, Business Development, Exosome Diagnostics
Attendee Quotes from the 2010 Next Generation Dx Summit:
“You and your team did a splendid job on your coverage of single cell detection diagnostics. The comments that I heard from several attendees were all very positive about the meeting.”
Professor of Radiology and Physics, and Director, University of Missouri Cancer Nanotechnology Platform; University of Missouri
“Good conference to learn new platform technologies for diagnostics."
Professor, Biotechnology, AIMST University, Malaysia
“The scope of the meeting was impressive, giving a good overview of commercial systems available as well as new technology options that meet the target features of POCS: fast, easy, cost-effective, accurate.”
Chief Scientific Officer, TREK Systems
“The meeting provided insight into the thinking of diverse stakeholders with unique scientific perspectives. It allowed participants an opportunity to network and to learn what their colleagues in the field are thinking.”
Associate Director, Technology Evaluation Center, Blue Cross and Blue Shield Association
Attendee Quotes from the 2009 Next Generation Dx Summit:
“The venue encourages interaction amongst all pertinent parties (developers, users, regulators) in a very effective manner.”
President, ACMC Medical Staff, Chairman, Pathology, Director, Clinical Laboratory, Alameda County Medical Center/Highland General Hospital
“Multi-faceted meeting that created new collaborations!”
Research Scientist, Lab of Molecular Technology, SAIC-NCI Frederick
“A proven conference for driving future diagnostics.”
“As our target market demands- all products/meetings should be right, relevant & rapid. This meeting hits all.”